Pharma & Biotech
The company has received applications in excess of A$1.3 million of the A$2 million SPP target.
Only registered members can use this feature.
Copyright © Proactive Investors 2020.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.